FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ashraf Badros

Research Profile

Disorders

Multiple Myeloma

Procedures

Chemicals & Drugs

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
C Fernández de Larrea; R Fonseca; R Hajek; S K Kumar; R A Kyle; J J Lahuerta; O Landgren; X Leleu; H Ludwig; A Mahindra; A Mazumber; U-H Mellqvist; G Merlini; P Moreau; A Noeul; R Z Orlowski; A Palumbo; P G Richardson; J F San Miguel; R Schots; O Sezer; K C Anderson; Ashraf Badros; J Bladé; J Caers; M Cavo; A Chanan-Khan; C S Chim; R Comenzo; M A Dimopoulos; B G M Durie; D Fantl; P Sonneveld; S Usmani; D H Vesole; J J Shah
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
Zhengping Wang; Alvin Wong; Tina Woo; Jinfu Yang; Melissa Alsina; Ashraf Badros; Darrin Bomba; Ying Fang; Christopher Kirk; Jin Li; Kyriakos Papadopoulos; Jeffrey R Infante
Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomib.
Rashid Z Khan; Ashraf Badros
Role of carfilzomib in the treatment of multiple myeloma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ashraf Badros (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: C Fernández de Larrea; R Fonseca; R Hajek; S K Kumar; R A Kyle; J J Lahuerta; O Landgren; X Leleu; H Ludwig; A Mahindra; A Mazumber; U-H Mellqvist; G Merlini; P Moreau; A Noeul; R Z Orlowski; A Palumbo; P G Richardson; J F San Miguel; R Schots; O Sezer; K C Anderson; Ashraf Badros; J Bladé; J Caers; M Cavo; A Chanan-Khan; C S Chim; R Comenzo; M A Dimopoulos; B G M Durie; D Fantl; P Sonneveld; S Usmani; D H Vesole; J J Shah
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
Leukemia 2013;27(4):780-91.
2013: Zhengping Wang; Alvin Wong; Tina Woo; Jinfu Yang; Melissa Alsina; Ashraf Badros; Darrin Bomba; Ying Fang; Christopher Kirk; Jin Li; Kyriakos Papadopoulos; Jeffrey R Infante
Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomib.
Drug metabolism and disposition: the biological fate of chemicals 2013;41(1):230-7.
2012: Rashid Z Khan; Ashraf Badros
Role of carfilzomib in the treatment of multiple myeloma.
Expert review of hematology 2012;5(4):361-72.
2012: Ashraf Badros
Lenalidomide in myeloma--a high-maintenance friend.
The New England journal of medicine 2012;366(19):1836-8.
2012: Geoffrey A Neuner; Ashraf Badros; Tanya K Meyer; Nahid M Nanaji; William F Regine
Complete resolution of laryngeal amyloidosis with radiation treatment.
Head & neck 2012;34(5):748-52.
2011: Gorgun Akpek; Maria Mikulski; Michael E Kleinberg; Ashraf Badros; Saul Yanovich; Aaron P Rapoport
Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis.
Blood 2011;117(21):5772-4.
2011: Aaron P Rapoport; Nicole A Aqui; Edward A Stadtmauer; Dan T Vogl; Hongbin Fang; Ling Cai; Stephen Janofsky; Anne Chew; Jan Storek; Gorgun Akpek; Ashraf Badros; Saul Yanovich; Ming Tan; Elizabeth Veloso; Marcela F Pasetti; Alan S Cross; Sunita Philip; Heather Murphy; Rita Bhagat; Zhaohui Zheng; Todd Milliron; Julio Cotte; Andrea Cannon; Bruce L Levine; Robert H Vonderheide; Carl H June
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.
Blood 2011;117(3):788-97.
2011: Ting Bao; Rui-Xin Zhang; Ashraf Badros; Lixing Lao
Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report.
Pain research and treatment 2011;2011():920807.
2010: Mouhamad Bazzi; Ashraf Badros
Multiple myeloma: Implementing signaling pathways and molecular biology in clinical trials.
Cancer biology & therapy 2010;10(9):830-8.
2010: Irene M Ghobrial; Wanling Xie; Swaminathan Padmanabhan; Ashraf Badros; Meghan Rourke; Renee Leduc; Stacey Chuma; Janet Kunsman; Diane Warren; Tiffany Poon; Brianna Harris; Amy Sam; Kenneth C Anderson; Paul G Richardson; Steve P Treon; Edie Weller; Jeffrey Matous
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.
American journal of hematology 2010;85(9):670-4.
2010: Paul G Richardson; Ashraf Badros; Sundar Jagannath; Stefano Tarantolo; Jeffrey L Wolf; Maher Albitar; David Berman; Marianne Messina; Kenneth C Anderson
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma.
British journal of haematology 2010;150(4):428-37.
2010: Wei-Gang Tong; Rong Chen; William Plunkett; David Siegel; Rajni Sinha; R Donald Harvey; Ashraf Badros; Leslie Popplewell; Steven Coutre; Judith A Fox; Kristi Mahadocon; Tianling Chen; Peggy Kegley; Ute Hoch; William G Wierda
Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(18):3015-22.
2010: Irene M Ghobrial; Fangxin Hong; Swaminathan Padmanabhan; Ashraf Badros; Meghan Rourke; Renee Leduc; Stacey Chuma; Janet Kunsman; Diane Warren; Brianna Harris; Amy Sam; Kenneth C Anderson; Paul G Richardson; Steven P Treon; Edie Weller; Jeffrey Matous
Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(8):1422-8.
2010: Betsy Paul; James A. Trovato; Jennifer Thompson; Ashraf Badros; Olga Goloubeva
Efficacy of aprepitant in patients receiving high-dose chemotherapy with hematopoietic stem cell support.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2010;16(1):45-51.
2010: Ashraf Badros
In the age of novel therapies, what defines high-risk multiple myeloma?
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8 Suppl 1():S28-34.
2010: Ashraf Badros
The role of maintenance therapy in the treatment of multiple myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8 Suppl 1():S21-7.
2010: Ruben Niesvizky; Ashraf Badros
Complications of multiple myeloma therapy, part 2: risk reduction and management of venous thromboembolism, osteonecrosis of the jaw, renal complications, and anemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8 Suppl 1():S13-20.
2009: Mark A Scheper; Ashraf Badros; Andrew R Salama; Gary Warburton; Kevin J Cullen; Dianna S Weikel; Timothy F Meiller
A novel bioassay model to determine clinically significant bisphosphonate levels.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009;17(12):1553-7.
2009: Ashraf Badros; Angelika Burger; Sunita Philip; Ruben Niesvizky; Sarah S Kolla; Olga Goloubeva; Carolynn Harris; James Zwiebel; John J Wright; Igor Espinoza-Delgado; Maria R Baer; Julianne L Holleran; Merrill J Egorin; Steven Grant
Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(16):5250-7.
2009: Paul Richardson; Sundar Jagannath; Mohamad Hussein; James Berenson; Seema Singhal; David Irwin; Stephanie F Williams; William Bensinger; Ashraf Badros; Robert Vescio; Laurie Kenvin; Zhinuan Yu; Marta Olesnyckyj; Jerome B Zeldis; Robert Knight; Kenneth C Anderson
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma.
Blood 2009;114(4):772-8.
2009: Mark A Scheper; Ashraf Badros; Risa Chaisuparat; Kevin J Cullen; Timothy F Meiller
Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.
British journal of haematology 2009;144(5):667-76.
2008: Ashraf Badros; Evangelos Terpos; Eirini Katodritou; Olga Goloubeva; Efstathios Kastritis; Evgenia Verrou; Kostas Zervas; Maria R Baer; Timothy F Meiller; Meletios A Dimopoulos
Natural history of osteonecrosis of the jaw in patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(36):5904-9.
2008: Ashraf Badros; Olga Goloubeva; Evangelos Terpos; Todd Milliron; Maria R Baer; Elizabeth A Streeten
Prevalence and significance of vitamin D deficiency in multiple myeloma patients.
British journal of haematology 2008;142(3):492-4.
2007: Edward A Stadtmauer; Sagar Lonial; David H Vesole; Rafat Abonour; Melissa Alsina; Ashraf Badros; Raymond Comenzo; Brian G M Durie; Sergio Giralt; Mohamad Hussein; Andrzej J Jakubowiak; Jayesh Mehta; Ruben Niesvizky; Robert Z Orlowski; David Siegel; Seema Singhal; Robert A Vescio; Michael Wang; Maurizio Zangari; Nikhil C Munshi
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
Clinical advances in hematology & oncology : H&O 2007;5(10 Suppl 15):7-19, quiz 21-2.
2007: Ashraf Badros; Olga Goloubeva; Jay S Dalal; Ilyas Can; Jennifer Thompson; Aaron P Rapoport; Meyer Heyman; Gorgun Akpek; Robert G Fenton
Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
Cancer 2007;110(5):1042-9.
2007: Ashraf Badros; Joyson Karakunnel; Nancy A Dawson
Multiple myeloma and renal cell carcinoma possible association.
Leukemia & lymphoma 2007;48(8):1662-4.
2007: Steve P Treon; Zachary R Hunter; Jeffrey Matous; Robin M Joyce; Brian Mannion; Ranjana Advani; David Cook; Joseph Songer; John Hill; Bruce R Kaden; David Sharon; Ronald Steiss; Xavier Leleu; Andrew R Branagan; Ashraf Badros
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3320-5.
2007: Michael E Mulligan; Ashraf Badros
PET/CT and MR imaging in myeloma.
Skeletal radiology 2007;36(1):5-16.
2006: Ashraf Badros; Olga Goloubeva; Robert G Fenton; Aaron P Rapoport; Gorgun Akpek; Carolynn Harris; Kathy Ruehle; Sandra Westphal; Barry Meisenberg
Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.
Clinical lymphoma & myeloma 2006;7(3):210-6.
2006: David Benderson; Joyson Karakunnel; Sajeev S Kathuria; Ashraf Badros
Scleritis complicating zoledronic acid infusion.
Clinical lymphoma & myeloma 2006;7(2):145-7.
2006: Richard J Breyer; Michael E Mulligan; Stacy E Smith; Bruce R Line; Ashraf Badros
Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma.
Skeletal radiology 2006;35(9):632-40.
2006: Benjamin Bridges; Sarah Donegan; Ashraf Badros
Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation.
American journal of hematology 2006;81(7):535-7.
2006: Choon-Kee Lee; Maurizio Zangari; AB Fassas; Raymond Thertulien; Giampaolo Talamo; Ashraf Badros; Michele Cottler-Fox; Frits van Rhee; Bart Barlogie; Guido Tricot
Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation.
Bone marrow transplantation 2006;37(5):511-5.
2006: Ashraf Badros; Dianna Weikel; Andrew Salama; Olga Goloubeva; Abraham Schneider; Aaron P Rapoport; Robert G Fenton; Natalie Gahres; Edward A Sausville; Robert A Ord; Timothy F Meiller
Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):945-52.
2006: April Deng; Valerie Harvey; Bahram Sina; David Strobel; Ashraf Badros; JACQUELINE JUNKINS-HOPKINS; Allen Samuels; Mana Oghilikhan; Anthony Gaspari
Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
Archives of dermatology 2006;142(2):198-202.
2005: Ashraf Badros; Natalie Gahres
Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait.
Clinical advances in hematology & oncology : H&O 2005;3(12):916-7; discussion 918.
2005: Aaron P Rapoport; Edward A Stadtmauer; Nicole Aqui; Ashraf Badros; Julio Cotte; Lisa Chrisley; Elizabeth Veloso; Zhaohui Zheng; Sandra Westphal; Rebecca Mair; Nina Chi; Bashi Ratterree; Mary Francis Pochran; Sabrina Natt; Joanne Hinkle; Cheryl Sickles; Ambika Sohal; Kathleen Ruehle; Christian Lynch; Lei Zhang; David Porter; Selina Luger; Chuanfa Guo; Hongbin Fang; William C Blackwelder; Kim G Hankey; Dean L Mann; Robert Edelman; Carl Frasch; Bruce L Levine; Alan S Cross; Carl H June
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.
Nature medicine 2005;11(11):1230-7.
2005: Ashraf Badros; Neil C Porter; Ann B Zimrin
Bevacizumab therapy for POEMS syndrome.
Blood 2005;106(3):1135.
2005: Ashraf Badros; Olga Goloubeva; Aaron P Rapoport; Bashi Ratterree; Natalie Gahres; Barry Meisenberg; Naoko Takebe; Meyer Heyman; James Zwiebel; Howard Streicher; Christopher D Gocke; Dragana Tomic; Jodi A Flaws; Bin Zhang; Robert G Fenton
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4089-99.
2005: Yoshio Inoue; Kathrina Chua; Rebecca F McClure; Manuel C Jimenez; Christopher D Gocke; Ashraf Badros; Naoko Takebe
Multiple myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascites.
Leukemia research 2005;29(6):715-8.
2005: Ashraf Badros
Case 38-2004: a large tumor of the skull.
The New England journal of medicine 2005;352(15):1610; author reply 1610.
2005: Morie A Gertz; Susan M Geyer; Ashraf Badros; Brad S Kahl; Charles Erlichman
Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenstrom's macroglobulinemia.
Clinical lymphoma 2005;5(4):282-4.
2005: Karl M Kasamon; Cinthia Drachenberg; Aaron P Rapoport; Ashraf Badros
Catastrophic antiphospholipid syndrome: atypical presentation in the setting of chronic graft versus host disease: case report and review of the literature.
Haematologica 2005;90(3):ECR17.
2004: Naoko Takebe; Xiangfei Cheng; Suhlan Wu; Kenneth S. Bauer; Olga Goloubeva; Robert G Fenton; Meyer Heyman; Aaron P Rapoport; Ashraf Badros; John Shaughnessy; Douglas Ross; Barry Meisenberg; Guido Tricot
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8301-8.
2004: Aaron P Rapoport; C Guo; Ashraf Badros; Roger Hakimian; Gorgun Akpek; E Kiggundu; Barry Meisenberg; Heather D Mannuel; Naoko Takebe; Robert G Fenton; F. JAVIER BOLANOS MEADE; Meyer Heyman; Ivana Gojo; Kathy Ruehle; S Natt; Bashi Ratterree; T Withers; Clarence Sarkodee-Adoo; Gordon L Phillips; Guido Tricot
Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.
Bone marrow transplantation 2004;34(10):883-90.
2004: Gordon L Phillips; Barry Meisenberg; Donna Reece; Val R Adams; Ashraf Badros; Janet Brunner; Robert G Fenton; Joanne Filicko; Dolores Grosso; gregory alan hale; Dianna S Howard; V P Johnson; AB Kniska; KW Marshall; R Nath; E Reed; Aaron P Rapoport; Naoko Takebe; David H Vesole; John L Wagner; Neal Flomenberg
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(7):473-83.
2004: Gordon L Phillips; Barry Meisenberg; Donna Reece; Val R Adams; Ashraf Badros; J L Brunner; Robert G Fenton; Joanne Filicko; D L Grosso; gregory alan hale; Dianna S Howard; V P Johnson; AB Kniska; KW Marshall; Bijoyesh Mookerjee; R Nath; Aaron P Rapoport; Clarence Sarkodee-Adoo; Naoko Takebe; David H Vesole; John L Wagner; Neal Flomenberg
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.
Bone marrow transplantation 2004;33(8):781-7.
2004: Aaron P Rapoport; B L Levine; Ashraf Badros; Barry Meisenberg; Kathy Ruehle; Asit K Nandi; S Rollins; S Natt; Bashi Ratterree; Sandra Westphal; Dean L Mann; C H June
Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells.
Bone marrow transplantation 2004;33(1):53-60.
2003: John Shaughnessy; Joth Jacobson; Jeffrey Sawyer; Jason McCoy; AB Fassas; Fenghuang Zhan; Klaus Bumm; Joshua Epstein; Elias Anaissie; Sundar Jagannath; David H Vesole; David Siegel; Raman Desikan; Nikhil Munshi; Ashraf Badros; Erming Tian; Maurizio Zangari; Guido Tricot; John Crowley; Bart Barlogie
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression.
Blood 2003;101(10):3849-56.
2003: F. JAVIER BOLANOS MEADE; Gordon L Phillips; Ashraf Badros
Tandem transplantation in multiple myeloma.
Oncology (Williston Park, N.Y.) 2003;17(3):389-98; discussion 398-400, 405-7.
2003: Choon-Kee Lee; Ashraf Badros; Bart Barlogie; Christopher Morris; Maurizio Zangari; AB Fassas; Frits van Rhee; Michele Cottler-Fox; Joth Jacobson; Raymond Thertulien; Firas Muwalla; Syed Mazher; Elias Anaissie; Guido Tricot
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning.
Experimental hematology 2003;31(1):73-80.
2002: Choon-Kee Lee; Bart Barlogie; Maurizio Zangari; AB Fassas; Elias Anaissie; Christopher Morris; Frits van Rhee; Michele Cottler-Fox; Raymond Thertulien; Firas Muwalla; S Mazher; Ashraf Badros; Guido Tricot
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
Bone marrow transplantation 2002;30(12):873-8.
2002: Nikhil C Munshi; Guido Tricot; Raman Desikan; Ashraf Badros; Maurizio Zangari; Amir Toor; C Morris; Elias Anaissie; Bart Barlogie
Clinical activity of arsenic trioxide for the treatment of multiple myeloma.
Leukemia 2002;16(9):1835-7.
2002: Ashraf Badros; Christopher Morris; Maurizio Zangari; Bart Barlogie; Guido Tricot
Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia.
Leukemia & lymphoma 2002;43(6):1267-71.
2002: AB Fassas; Christopher Morris; Ashraf Badros; Frits van Rhee; Guido Tricot
Separating graft-versus-tumor from graft-versus-host reactions.
Leukemia & lymphoma 2002;43(4):725-33.
2002: Maurizio Zangari; Fariba Saghafifar; Elias Anaissie; Ashraf Badros; Raman Desikan; AB Fassas; Paulette Mehta; Christopher Morris; Amir Toor; D Whitfield; Eric Siegel; Bart Barlogie; Louis Fink; Guido Tricot
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(3):187-92.
2002: AB Fassas; Firas Muwalla; Tanya Berryman; Riad Benramdane; Lija Joseph; Elias Anaissie; Rajesh Sethi; Raman Desikan; David Siegel; Ashraf Badros; Amir Toor; Maurizio Zangari; Christopher Morris; Edgardo Angtuaco; Sajini Mathew; Carla Wilson; Aubrey Hough; Sami I Harik; Bart Barlogie; Guido Tricot
Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.
British journal of haematology 2002;117(1):103-8.
2002: Ashraf Badros; Eric Siegel; Donald L Bodenner; Maurizio Zangari; Jerome B Zeldis; Bart Barlogie; Guido Tricot
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
The American journal of medicine 2002;112(5):412-3.
2002: Ashraf Badros; Bart Barlogie; Eric Siegel; Michele Cottler-Fox; Maurizio Zangari; AB Fassas; Christopher Morris; Elias Anaissie; Frits van Rhee; Guido Tricot
Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1295-303.
2002: Aaron P Rapoport; Barry Meisenberg; Clarence Sarkodee-Adoo; AB Fassas; Stanley R Frankel; Bijoyesh Mookerjee; Naoko Takebe; Robert G Fenton; Meyer Heyman; Ashraf Badros; A Kennedy; M Jacobs; Richard S Hudes; Kathy Ruehle; R Smith; L Kight; S Chambers; M MacFadden; Michele Cottler-Fox; T Chen; G Phillips; Guido Tricot
Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy.
Bone marrow transplantation 2002;29(4):303-12.
2002: Ashraf Badros; Guido Tricot; Amir Toor; Christopher Morris; Chuanfa Guo; Nikhil Munshi; Bart Barlogie; Michele Cottler-Fox
ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning.
Transfusion 2002;42(2):205-9.
2002: Guido Tricot; Horace Spencer; Jeffrey Sawyer; Dan Spoon; Raman Desikan; AB Fassas; Ashraf Badros; Maurizio Zangari; Nikhil Munshi; Elias Anaissie; Amir Toor; Bart Barlogie
Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants.
British journal of haematology 2002;116(1):211-7.
2001: Ashraf Badros; Bart Barlogie; Eric Siegel; J Roberts; C Langmaid; Maurizio Zangari; Raman Desikan; Mary J Shaver; AB Fassas; S McConnell; Firas Muwalla; Yousri M Barri; Elias Anaissie; Nikhil Munshi; Guido Tricot
Results of autologous stem cell transplant in multiple myeloma patients with renal failure.
British journal of haematology 2001;114(4):822-9.
2001: Ashraf Badros; Bart Barlogie; Eric Siegel; Christopher Morris; Raman Desikan; Maurizio Zangari; AB Fassas; Elias Anaissie; Nikhil Munshi; Guido Tricot
Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years.
British journal of haematology 2001;114(3):600-7.
2001: Maurizio Zangari; Elias Anaissie; Bart Barlogie; Ashraf Badros; Raman Desikan; A V Gopal; Christopher Morris; Amir Toor; Eric Siegel; Louis Fink; Guido Tricot
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.
Blood 2001;98(5):1614-5.
2001: Bart Barlogie; Raman Desikan; Paul Eddlemon; Horace Spencer; Jerome B Zeldis; Nikhil Munshi; Ashraf Badros; Maurizio Zangari; Elias Anaissie; Joshua Epstein; John Shaughnessy; D Ayers; Dan Spoon; Guido Tricot
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients.
Blood 2001;98(2):492-4.
2001: Bart Barlogie; Maurizio Zangari; Horace Spencer; AB Fassas; Elias Anaissie; Ashraf Badros; Jeana Cromer; Guido Tricot
Thalidomide in the management of multiple myeloma.
Seminars in hematology 2001;38(3):250-9.
2001: Ashraf Badros; Bart Barlogie; Christopher Morris; Raman Desikan; S R Martin; Nikhil Munshi; Maurizio Zangari; Jayesh Mehta; Amir Toor; Michele Cottler-Fox; AB Fassas; Elias Anaissie; Steven A Schichman; Guido Tricot; E Aniassie
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions.
Blood 2001;97(9):2574-9.
2001: Anthony W Butch; Ashraf Badros; KR Desikan; Nikhil C Munshi
Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma.
Bone marrow transplantation 2001;27(6):663-6.
2001: S H Lim; Ashraf Badros; C Lue; Bart Barlogie
Distinct T-cell clonal expansion in the vicinity of tumor cells in plasmacytoma.
Cancer 2001;91(5):900-8.
2001: KR Desikan; Guido Tricot; Nikhil C Munshi; Elias Anaissie; Dan Spoon; AB Fassas; Amir Toor; Maurizio Zangari; Ashraf Badros; Christopher Morris; David H Vesole; David Siegel; Sundar Jagannath; Bart Barlogie
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone.
British journal of haematology 2001;112(1):242-7.
2000: John Shaughnessy; Erming Tian; Jeffrey Sawyer; Klaus Bumm; Reid D Landes; Ashraf Badros; Christopher Morris; Guido Tricot; Joshua Epstein; Bart Barlogie
High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH.
Blood 2000;96(4):1505-11.
2000: Raman Desikan; Bart Barlogie; Jeffrey Sawyer; D Ayers; Guido Tricot; Ashraf Badros; Maurizio Zangari; Nikhil C Munshi; Elias Anaissie; Dan Spoon; David Siegel; Sundar Jagannath; David H Vesole; Joshua Epstein; John Shaughnessy; AB Fassas; S Lim; P Roberson; John Crowley
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities.
Blood 2000;95(12):4008-10.
1997: Kenneth R Meehan; Ashraf Badros; Stanley R Frankel; R Cahill; Ellen M Areman; M Jenson; Ronald A Sacher; A Mazumder
A pilot study evaluating interleukin-2-activated hematopoietic stem cell transplantation for hematologic malignancies.
Journal of hematotherapy 1997;6(5):457-64.